Shopping Cart 0
Cart Subtotal
USD 0

DexCom Inc (DXCM)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

DexCom Inc (DXCM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company's major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom's in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

DexCom Inc Key Recent Developments

May 02,2017: DexCom Reports First Quarter 2017 Financial Results

Mar 13,2017: DexCom Appoints Richard Collins to Board of Directors

Feb 28,2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Jan 10,2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook

Nov 14,2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

DexCom Inc-Key Facts 6

DexCom Inc-Key Employees 7

DexCom Inc-Key Employee Biographies 8

DexCom Inc-Major Products and Services 9

DexCom Inc-Medical Equipment Pipeline Products Data 10

DexCom Inc Pipeline Products by Equipment Type 10

DexCom Inc Pipeline Products by Development Stage 11

DexCom Inc-History 13

DexCom Inc-Company Statement 15

DexCom Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

DexCom Inc-Business Description 18

DexCom Inc-Corporate Strategy 19

DexCom Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

DexCom Inc-Strengths 20

DexCom Inc-Weaknesses 21

DexCom Inc-Opportunities 22

DexCom Inc-Threats 23

DexCom Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

DexCom Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

DexCom Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 34

Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 35

Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 36

Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 37

Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 38

Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 39

Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes 40

Sep 07, 2016: Reimbursement of Dexcom CGM Technology for Patients with Type 1 and Type 2 Insulin-Dependent Diabetes is Now Available in Germany 41

Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 42

Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

DexCom Inc Pipeline Products by Equipment Type 10

DexCom Inc Pipeline Products by Development Stage 11

DexCom Inc, Performance Chart (2012-2016) 28

DexCom Inc, Ratio Charts 30

DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

DexCom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 32


List Of Table

List of Tables

DexCom Inc, Key Facts 6

DexCom Inc, Key Employees 7

DexCom Inc, Key Employee Biographies 8

DexCom Inc, Major Products and Services 9

DexCom Inc Pipeline Products by Equipment Type 10

DexCom Inc Number of Pipeline Products by Development Stage 11

DexCom Inc Pipeline Products Summary by Development Stage 12

DexCom Inc, History 13

DexCom Inc, Subsidiaries 17

DexCom Inc, Key Competitors 24

DexCom Inc, Ratios based on current share price 25

DexCom Inc, Annual Ratios 26

DexCom Inc, Annual Ratios (Cont...1) 27

DexCom Inc, Interim Ratios 29

DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

DexCom Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

DexCom Inc, Recent Deals Summary 33

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

DexCom Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts